DOW JONES26,957.59-123.77 -0.46%
S&P 5003,116.39-11.82 -0.38%
NASDAQ8,980.78+15.16 0.17%

H.C. Wainwright Reiterates Buy on Neurocrine Biosciences, Raises Price Target to $125

H.C. Wainwright reiterates Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and raises the price target from $102 to $125.

Benzinga · 02/05/2020 12:15

H.C. Wainwright reiterates Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and raises the price target from $102 to $125.